BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34247526)

  • 1. The Impact of Corticosteroids on Secondary Infection and Mortality in Critically Ill COVID-19 Patients.
    Ritter LA; Britton N; Heil EL; Teeter WA; Murthi SB; Chow JH; Ricotta E; Chertow DS; Grazioli A; Levine AR
    J Intensive Care Med; 2021 Oct; 36(10):1201-1208. PubMed ID: 34247526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation.
    De Bruyn A; Verellen S; Bruckers L; Geebelen L; Callebaut I; De Pauw I; Stessel B; Dubois J
    BMC Infect Dis; 2022 Mar; 22(1):207. PubMed ID: 35236299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study.
    Li Y; Meng Q; Rao X; Wang B; Zhang X; Dong F; Yu T; Li Z; Feng H; Zhang J; Chen X; Li H; Cheng Y; Hong X; Wang X; Yin Y; Zhang Z; Wang D
    Crit Care; 2020 Dec; 24(1):698. PubMed ID: 33339536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region.
    Majmundar M; Kansara T; Lenik JM; Park H; Ghosh K; Doshi R; Shah P; Kumar A; Amin H; Chaudhari S; Habtes I
    PLoS One; 2020; 15(9):e0238827. PubMed ID: 32903258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary bloodstream infection in critically ill patients with COVID-19.
    Zhang J; Lan P; Yi J; Yang C; Gong X; Ge H; Xu X; Liu L; Zhou J; Lv F
    J Int Med Res; 2021 Dec; 49(12):3000605211062783. PubMed ID: 34898307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study.
    Monedero P; Gea A; Castro P; Candela-Toha AM; Hernández-Sanz ML; Arruti E; Villar J; Ferrando C;
    Crit Care; 2021 Jan; 25(1):2. PubMed ID: 33397463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients.
    Moreno G; Ruiz-Botella M; Martín-Loeches I; Gómez Álvarez J; Jiménez Herrera M; Bodí M; Armestar F; Marques Parra A; Estella Á; Trefler S; Jorge García R; Murcia Paya J; Vidal Cortes P; Díaz E; Ferrer R; Albaya-Moreno A; Socias-Crespi L; Bonell Goytisolo JM; Sancho Chinesta S; Loza A; Forcelledo Espina L; Pozo Laderas JC; deAlba-Aparicio M; Sánchez Montori L; Vallverdú Perapoch I; Hidalgo V; Fraile Gutiérrez V; Casamitjana Ortega AM; Martín Serrano F; Nieto M; Blasco Cortes M; Marín-Corral J; Solé-Violán J; Rodríguez A;
    Med Intensiva (Engl Ed); 2023 Jan; 47(1):23-33. PubMed ID: 36272908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study.
    Torres A; Motos A; Cillóniz C; Ceccato A; Fernández-Barat L; Gabarrús A; Bermejo-Martin J; Ferrer R; Riera J; Pérez-Arnal R; García-Gasulla D; Peñuelas O; Lorente JÁ; de Gonzalo-Calvo D; Almansa R; Menéndez R; Palomeque A; Villar RA; Añón JM; Balan Mariño A; Barberà C; Barberán J; Blandino Ortiz A; Boado MV; Bustamante-Munguira E; Caballero J; Cantón-Bulnes ML; Carbajales Pérez C; Carbonell N; Catalán-González M; de Frutos R; Franco N; Galbán C; Gumucio-Sanguino VD; de la Torre MDC; Díaz E; Estella Á; Gallego E; García Garmendia JL; Gómez JM; Huerta A; García RNJ; Loza-Vázquez A; Marin-Corral J; Martin Delgado MC; Martínez de la Gándara A; Martínez Varela I; López Messa J; Albaiceta GM; Nieto M; Novo MA; Peñasco Y; Pérez-García F; Pozo-Laderas JC; Ricart P; Sagredo V; Sánchez-Miralles A; Sancho Chinesta S; Serra-Fortuny M; Socias L; Solé-Violan J; Suarez-Sipmann F; Tamayo Lomas L; Trenado J; Úbeda A; Valdivia LJ; Vidal P; Barbé F;
    Intensive Care Med; 2022 Jul; 48(7):850-864. PubMed ID: 35727348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study.
    Al Sulaiman K; Aljuhani O; Al Aamer K; Al Shaya O; Al Shaya A; Alsaeedi AS; Alhubaishi A; Altebainawi AF; Al Harthi A; Albelwi S; Almutairi R; Alsubaie N; Alsallum A; Korayem GB; Alfahed A; Kensara R; Altebainawi EF; Alenezi RS; Alsulaiman T; Al Enazi H; Vishwakarma R; Al Dabbagh T; Bakhsh U; Al Ghamdi G
    J Intensive Care Med; 2022 Feb; 37(2):248-257. PubMed ID: 34757869
    [No Abstract]   [Full Text] [Related]  

  • 12. Association between different corticosteroid regimens used in severe SARS-CoV-2 infection and short-term mortality: retrospective cohort study.
    González-Castro A; Fernandez A; Cuenca-Fito E; Peñasco Y; Ceña J; Rodríguez Borregán JC
    Rev Esp Anestesiol Reanim (Engl Ed); 2024 May; 71(5):379-386. PubMed ID: 38395302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between continuous renal replacement therapy and 28-day mortality of critically ill patients with COVID-19 receiving mechanical ventilation.
    Xu X; Liu K; Cheng P; Huang Y; Huang C; Wu W; Xing C; Mao H; Liu Y
    Clin Nephrol; 2021 Oct; 96(4):207-215. PubMed ID: 34236306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.
    Ferrando C; Mellado-Artigas R; Gea A; Arruti E; Aldecoa C; Bordell A; Adalia R; Zattera L; Ramasco F; Monedero P; Maseda E; Martínez A; Tamayo G; Mercadal J; Muñoz G; Jacas A; Ángeles G; Castro P; Hernández-Tejero M; Fernandez J; Gómez-Rojo M; Candela Á; Ripollés J; Nieto A; Bassas E; Deiros C; Margarit A; Redondo FJ; Martín A; García N; Casas P; Morcillo C; Hernández-Sanz ML;
    Rev Esp Anestesiol Reanim (Engl Ed); 2020 Oct; 67(8):425-437. PubMed ID: 32800622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary infections in critically ill patients with COVID-19 receiving steroid therapy.
    Pearce AK; Zawaydeh Q; McGuire WC; Husain A; Ayoub C; Sweeney DA; Cotton SA; Malhotra A
    Sci Prog; 2023; 106(4):368504231207209. PubMed ID: 37899703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set.
    Conway Morris A; Kohler K; De Corte T; Ercole A; De Grooth HJ; Elbers PWG; Povoa P; Morais R; Koulenti D; Jog S; Nielsen N; Jubb A; Cecconi M; De Waele J;
    Crit Care; 2022 Aug; 26(1):236. PubMed ID: 35922860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacterial coinfection in the critically-ill COVID-19 patient: incidence, impact and need for antimicrobial therapy].
    Vidal-Cortés P; Nieto Del Olmo J; Tizón Varela AI; Seoane Fernández E; Eiras Abalde F; Blanco Chapela J; Larrañaga Sigwald L; Suárez Fernández DE; Fernández Ugidos P; Del Río Carbajo L
    Rev Esp Quimioter; 2023 Dec; 36(6):612-620. PubMed ID: 37743661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The modified NUTRIC score can be used for nutritional risk assessment as well as prognosis prediction in critically ill COVID-19 patients.
    Zhang P; He Z; Yu G; Peng D; Feng Y; Ling J; Wang Y; Li S; Bian Y
    Clin Nutr; 2021 Feb; 40(2):534-541. PubMed ID: 32527576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill Patients With COVID-19 With Hyperinflammatory Phenotype.
    Chen H; Xie J; Su N; Wang J; Sun Q; Li S; Jin J; Zhou J; Mo M; Wei Y; Chao Y; Hu W; Du B; Qiu H
    Chest; 2021 May; 159(5):1793-1802. PubMed ID: 33316235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungal infection profile in critically ill COVID-19 patients: a prospective study at a large teaching hospital in a middle-income country.
    Negm EM; Mohamed MS; Rabie RA; Fouad WS; Beniamen A; Mosallem A; Tawfik AE; Salama HM
    BMC Infect Dis; 2023 Apr; 23(1):246. PubMed ID: 37072718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.